Research indicates that CLU expression and circulating levels increase with obesity and visceral adiposity, correlating with chronic low-grade inflammation, high-sensitivity C-reactive protein (hs-CRP), retinol-binding protein-4, and other proinflammatory markers [13]. This evidence concerns the gene RBP4 and obesity due to melanocortin 4 receptor deficiency.